NCT03958344 is a Phase 3 clinical trial of Prednisolone in Orbital Pseudotumor, sponsored by Iran University of Medical Sciences.

Who is sponsoring NCT03958344?

NCT03958344 is sponsored by Iran University of Medical Sciences.

What drugs are being tested in NCT03958344?

Interventions in NCT03958344: Prednisolone, Triamcinolone + Betamethason.

What condition does NCT03958344 study?

NCT03958344 studies Orbital Pseudotumor.

Is NCT03958344 still recruiting?

NCT03958344 is currently status unknown. Last updated 16 February 2023.

Last reviewed 2023-02-16 · How we verify

NCT03958344

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intraorbital Injection Versus Oral Steroid in Anterior Idiopathic Orbital Inflammation

Status unknown Phase 3 Last updated 16 February 2023

What this trial tests

Phase 3 trial testing Prednisolone in Orbital Pseudotumor in 120 participants. Status unknown.

Timeline

1 January 2022

Primary endpoint
1 June 2024

1 June 2025

Quick facts

Lead sponsor	Iran University of Medical Sciences
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	120
Start date	1 January 2022
Primary completion	1 June 2024
Estimated completion	1 June 2025
Sites	1 location across Iran

Drugs / interventions tested

Prednisolone — full drug profile →
Triamcinolone + Betamethason — full drug profile →

Conditions studied

Orbital Pseudotumor — all drugs for Orbital Pseudotumor →

Sponsor

Iran University of Medical Sciences

Who can join

15 and older, any sex, with Orbital Pseudotumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A multicenter randomised double-arm clinical trial, to compare safety and efficacy of oral versus intralesional injection of steroid in a group of patients suffering from idiopathic orbital inflammation is designed. Outcome measures include number of recurrences, duration of remission, and side effects.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Nonspecific Orbital Inflammation (NSOI): Unraveling the Molecular Pathogenesis, Diagnostic Modalities, and Therapeutic Interventions.
Wu KY, Kulbay M, Daigle P, Nguyen BH, et al · · 2024 · cited 13× · PMID 38338832 · DOI 10.3390/ijms25031553

Verify or expand the search:

Other trials of Prednisolone

Trials testing the same drug.

NCT07072585 — Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leuk · Phase 2, PHASE3 · not yet recruiting
NCT07210008 — "Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity · Phase 3 · not yet recruiting
NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
NCT07052929 — Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators · Phase 1, PHASE2 · recruiting
NCT07252271 — Very Low Dose Prednisolone on Newly Diagnosed Rheumatoid Arthritis · Phase 4 · not yet recruiting

Other Iran University of Medical Sciences trials

Trials by the same sponsor.

NCT06763627 — The Effectiveness of Gamification vs. Traditional Teaching in Undergraduate Medical Education · NA · completed
NCT05383365 — Deep Neck Flexor Exercises Versus Myofascial Release of Suboccipital Muscles in Chronic Tension-type Headache · NA · not yet recruiting
NCT06193603 — Cupping Therapy in Chronic Nonspecific Low Back Pain · NA · completed
NCT06543667 — Limbal Stem Cell Derived Exosome (LSC-Exo) Eye Drop for Treatment of Dry Eye · Phase 1 · recruiting
NCT05316142 — Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03958344 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Iran University of Medical Sciences
Last refreshed: 16 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03958344.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing